Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Understanding how the IRA’s multiple provisions interact to induce cost-related change The Inflation Reduction Act (IRA) ushers in numerous changes for the pharmaceutical sector. The law is recognizable for its two headliner provisions: Mandated Part...